News

UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into GLP-1 medicines after worrying ...
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility ...
The weight-loss injection boom that swept through Hollywood and boardrooms alike is now facing a potentially deadly reckoning ...
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...